Sign in
CompletedNo phase

Effects of Esketamine at Subanesthetic Dose on Emergence Delirium in Preschool Children Undergoing Ambulatory Laparoscopic Surgery

Key facts

Who runs it
Qiu jinpeng
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
96 people enrolled
Started
7 Feb 2025
Ended
16 May 2025
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • 0.1mg/kg esketamine
  • 0.2mg/kg esketamine
  • 0.1ml/kg normal saline
Record updated
22 May 2025

Who can take part

Age
24 months to 71 months
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • laparoscopic inguinal hernia repair under general anesthesia
  • aged 24~71 months
  • American Society of Anesthesiologists Physical Status I or II
  • body mass index for age between the 5th and 85th percentiles

Who cannot take part

  • allergy to esketamine
  • glaucoma or neurological disorders
  • asthma or respiratory infection in the last 2 weeks
  • abnormal liver or kidney function
  • cardiovascular or endocrine dysfunction
  • developmental delay

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Emergence delirium (ED) is a manifestation of acute postoperative brain dysfunction that occurs with a relatively high frequency after pediatric anesthesia. The incidence varies depending on the diagnostic criteria used and the combination of administered anesthetic drugs. The goal of this clinical trial is to investigate whether a subanesthetic dose of esketamine can reduce incidence of ED.

The 3 groups in the trial

  • group S1 (0.1mg/kg esketamine)Treatment being tested

    Treatment: 0.1mg/kg esketamine

  • group S2 (0.2mg/kg esketamine)Treatment being tested

    Treatment: 0.2mg/kg esketamine

  • group C (0.1ml/kg Normal saline)Placebo, for comparison

    Treatment: 0.1ml/kg normal saline

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
22 May 2025